Author details

Full Name

Angela Baker

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36578607	The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profiling.		2023
33316362	Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.	Int J Radiat Oncol Biol Phys	2021
31809876	Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.	Int J Radiat Oncol Biol Phys	2020
31767473	A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.	Radiother Oncol	2020
30663451	Personalised medicine in inflammatory bowel diseases: a patient survey.	Scandinavian Journal of Gastroenterology	2019
31388568	Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.	Clinical and Translational Radiation Oncology	2019
32095567	A new era for clinical trial quality assurance: A credentialing programme for RTT led adaptive radiotherapy.	Technical Innovations and Patient Support in Radiation Oncology	2018
28057415	Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.	Clin Genitourin Cancer	2017
28003660	Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.	Sci Rep	2016
27296040	IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.	Int J Radiat Oncol Biol Phys	2016
27094764	A somatic reference standard for cancer genome sequencing.	Sci Rep	2016
26585543	A multicentre study of the evidence for customized margins in photon breast boost radiotherapy.	British Journal of Radiology	2016
24943349	Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.	BMC Med Genomics	2014
24071583	Long insert whole genome sequencing for copy number variant and translocation detection.	Nucleic Acids Res	2014
24418928	Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.	Int J Gynecol Cancer	2014
24489661	Integrated genomic and epigenomic analysis of breast cancer brain metastasis.	PLoS One	2014
24550739	Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.	PLoS Genet	2014
23716545	Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.	Haematologica	2013
24204627	A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges.	PLoS One	2013
23480694	Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.	Br J Haematol	2013
23422747	Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.	Blood	2013
23171949	Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.	Mol Cancer Ther	2013
23071490	Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.	PLoS One	2012
22649506	Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.	PLoS One	2012
22498740	Clonal competition with alternating dominance in multiple myeloma.	Blood	2012
22762308	Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability.	Genome Med	2012
21147910	Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors.	Genome Res	2011
21430775	Initial genome sequencing and analysis of multiple myeloma.	Nature	2011
20220778	Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.	Leukemia	2010
20736376	DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors.	Cancer Research	2010
17692805	Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.	Cancer Cell	2007
15046703	Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer.	Clin Prostate Cancer	2002